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Background: Electroporation based therapies and treatments (e.g. electrochemotherapy,
gene electrotransfer for gene therapy and DNA vaccination, tissue ablation with
irreversible electroporation and transdermal drug delivery) require a precise prediction of
the therapy or treatment outcome by a personalized treatment planning procedure.
Numerical modeling of local electric field distribution within electroporated tissues has
become an important tool in treatment planning procedure in both clinical and
experimental settings. Recent studies have reported that the uncertainties in electrical
properties (i.e. electric conductivity of the treated tissues and the rate of increase in
electric conductivity due to electroporation) predefined in numerical models have large
effect on electroporation based therapy and treatment effectiveness. The aim of our
study was to investigate whether the increase in electric conductivity of tissues needs to
be taken into account when modeling tissue response to the electroporation pulses and
how it affects the local electric distribution within electroporated tissues.
Methods: We built 3D numerical models for single tissue (one type of tissue, e.g. liver)
and composite tissue (several types of tissues, e.g. subcutaneous tumor). Our computer
simulations were performed by using three different modeling approaches that are
based on finite element method: inverse analysis, nonlinear parametric and sequential
analysis. We compared linear (i.e. tissue conductivity is constant) model and non-
linear (i.e. tissue conductivity is electric field dependent) model. By calculating
goodness of fit measure we compared the results of our numerical simulations to
the results of in vivo measurements.
Results: The results of our study show that the nonlinear models (i.e. tissue
conductivity is electric field dependent: σ(E)) fit experimental data better than
linear models (i.e. tissue conductivity is constant). This was found for both single
tissue and composite tissue. Our results of electric field distribution modeling in
linear model of composite tissue (i.e. in the subcutaneous tumor model that do
not take into account the relationship σ(E)) showed that a very high electric field
(above irreversible threshold value) was concentrated only in the stratum corneum
while the target tumor tissue was not successfully treated. Furthermore, the
calculated volume of the target tumor tissue exposed to the electric field above
reversible threshold in the subcutaneous model was zero assuming constant
conductivities of each tissue.
Our results also show that the inverse analysis allows for identification of both
baseline tissue conductivity (i.e. conductivity of non-electroporated tissue) and
tissue conductivity vs. electric field (σ(E)) of electroporated tissue.
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Conclusion: Our results of modeling of electric field distribution in tissues during
electroporation show that the changes in electrical conductivity due to electroporation
need to be taken into account when an electroporation based treatment is planned or
investigated. We concluded that the model of electric field distribution that takes into
account the increase in electric conductivity due to electroporation yields more precise
prediction of successfully electroporated target tissue volume. The findings of our study
can significantly contribute to the current development of individualized patient-specific
electroporation based treatment planning.
Keywords: Electroporation, Numerical modeling, Inverse analysis, Electric field
distribution, Tissue conductivity, Liver electroporation, Tumor electroporationBackground
Electroporation is an increase of cell membrane permeability to molecules that other-
wise lack efficient transmembrane transport mechanisms. Due to membrane electro-
poration cell membrane conductivity is also increased. Electroporation can be achieved
if cells are exposed to a sufficiently high electric field induced by application of high
voltage pulses (i.e. electroporation pulses) [1-3]. The efficiency of electroporation
strongly depends on pulse parameters such as pulse amplitude, pulse duration, number
of pulses and repetition frequency [4]. In order to successfully electropermeabilize a cell
membrane the induced transmembrane voltage needs to exceed a given value that de-
pends on cell or tissue type (e.g. cell geometry, cell density, cell’s shape and orientation
with respect to the electric field) [5-9]. It has been demonstrated that all types of cells
(e.g. human, animal, plant and microorganisms) can be effectively electroporated, pro-
vided that appropriate electroporation parameters are selected for each of the cell or
tissue type [10]. One of the key parameters for effective cell and tissue electroporation
is however adequate electric field distribution within the treated sample [11]. The local
electric field induces the transmembrane voltage on the cell [12,13], which is in turn
correlated with transmembrane flux [3]. A cell or tissue is reversibly electroporated
when the local electric field exceeds a reversible threshold value (Erev) [14-16]. If the
local electric field however exceeds an irreversible threshold (Eirrev) value the mem-
branes of the exposed cells are disrupted to such an extent that cells fail to recover and
they die (i.e. irreversible electroporation) [17-19].
Increase in cell membrane permeability allows for both administration of different
molecules into electroporated cells (such as therapeutic drugs or molecular probes,
which otherwise can not enter the cytosol) and for extraction of different cell compo-
nents out from the cells [20,21]. Since, electroporation has been demonstrated to be a
versatile method for both in vitro and in vivo settings it has been successfully applied
to various domains such as medicine (e.g. human and veterinary oncology) [22-27],
food processing [28] and microbial inactivation in water treatment [29].
Medical electroporation based therapies and treatments such as electrochemotherapy
in local tumor control [27,30], tissue ablation method by means of irreversible electro-
poration [31,32] and gene therapy and DNA based vaccination by means of gene
electrotransfer [33,34] are paving their way into clinical practice. In particular,
electrochemotherapy has been demonstrated as an efficient tumor treatment as 85%
objective response was obtained in treating skin metastasis of various cancers. In 2006
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treatment of easily accessible cutaneous and subcutaneous tumor nodules of different
histologies [35]. The SOP for electrochemotherapy were defined based on external pa-
rameters such as amplitude of applied voltage and distance between electrodes based
on preclinical results and the results of numerical calculations in 3D models (1300 V/
cm and 1000 V/cm for plate and needle electrodes respectively) [13,15]. The efficacy of
SOP for easily accessible cutaneous tumors and subcutaneous tumor (depth: less than
2 cm) nodules were later confirmed by numerous clinical studies [30,36-38]. The
in vivo studies that were based also on numerical simulations further demonstrated that
the protocols of cutaneous tumors can be refined and that the electrochemotherapy
can be successfully applied to deep-seated tumors based on analysis of local electric
field distribution within the tumors [39,40]. In our previous study [41] we demon-
strated that better electrochemotherapy outcome of cutaneous tumors can be obtained
with increase of contact surface between plate electrodes and treated tissue. Similarly,
Ivorra and colleagues [42] proposed the use of conductive gels in order to ‘homogenize’
the electric field within the treated tissue of easily accessible cutaneous tumors. How-
ever, for deep-seated tumors and tumors in internal organs, such as for example liver,
brain or muscle tissue that are surrounded by other tissues having different electric
properties an individualized patient-specific treatment planning is required as the het-
erogeneity of local electric field distribution within all exposed tissues can not be
neglected [43,44]. Namely, several preclinical and clinical studies have shown that
deep-seated tumors located in internal organs (breast cancer [27,37], bone metastasis
[45], brain [46], liver metastases [40], melanoma metastasis in the muscle [39]) are also
treatable. The outcome of the treatment however greatly depends on positioning of the
electrodes, on applying of adequate pulses, electrode geometry and electrical properties
of the treated tissues. These findings were either predicted or confirmed with numerical
simulations, which resulted in development of computer-based treatment planning
of both reversible electroporation based therapies (such as electrochemotherapy
[43,44,47-49] and gene therapy and vaccination [50]) and irreversible electroporation
based therapies [47,51-53]. Development of treatment planning of electroporation
based therapies is currently focused on analysis of the shape and position of electrodes
used and applied voltage to the electrodes [40,44,54,55]. Numerous studies demon-
strated that the conductivity is increased due to membrane electroporation [2,56,57]
and that in calculating the local electric field distribution within treated tissue one
needs to account for these tissue conductivity increases [9,16,47,58,59]. In preclinical
and clinical studies authors however often consider the treated tissues as being linear
electric conductors (i.e. with constant tissue conductivities).
The aim of our study was to investigate whether the increase in electric conductivity
of tissues needs to be taken into account when modeling tissue response to the electro-
poration pulses and how it affects the local electric field distribution within
electroporated tissues. We also attempted to identify the nature of functional dependency
of tissue conductivity on electric field. We therefore compared linear (i.e. tissue conductiv-
ity is constant) and non-linear (i.e. tissue conductivity is electric field dependent) model to
the experimental data in vivo [56]. The study was performed for both single tissue (one
type of tissue, e.g. liver) and composite tissue (several types of tissues, e.g. subcutaneous
tumor). Our computer simulations were performed by using three different modeling
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and 3. sequential analysis (SA) [58]. The algorithm for IA modelling approach has
been previously developed by [60,61] to model different physical phenomena in wide
range of research and industry including biomechanics, pharmaceutical industry and
space [63]. In this paper we introduced and successfully applied the IA approach for
the first time in the field of modelling of biophysical processes that occur during tis-
sue electroporation.
The results of all three modeling approaches are then compared to the results of
our previous experimental measurements in vivo [56]. The results of our present
study show that the nonlinear models fit experimental data better than linear
models. We also demonstrate that tissue conductivity as a function of local electric
field need to be taken into account when an electroporation based therapy or treat-
ment is planned.Materials and methods
In order to investigate the change of electric properties of tissues on the electric field
distribution during electroporation we built 3D numerical models of single tissue and
composite tissue.
Modeling of electric field distribution in a single tissue during electroporation was
carried out in liver tissue. We analyzed experimental data for plate and needle elec-
trodes. Original experiments with plate electrodes were performed in rat liver, while
the experiments with needle electrodes were performed in rabbit liver [56].
Modeling of electric field distribution in composite tissue (i.e. tissue composed of dif-
ferent types of tissues) was carried out in cutaneous tumor tissue. In vivo experiments
were performed in mice with plate electrodes for two different types of cutaneous tu-
mors: B16 and LPB sarcoma within the study by [56].
The high voltage pulses in all in vivo experiments were applied to the electrodes
according to the electroporation protocol of eight 100 μs long pulses delivered to the
tissues with 1 Hz repetition frequency. Within the experiments [56] the real time tissue
electroporation control was performed by monitoring and measuring the electric
current during the delivery of electric pulses. In order to evaluate the tissue electropor-
ation efficiency during the pulse delivery the 51CrEDTA indicator was used for all tis-
sues. The system for the real time tissue electroporation control and 51CrEDTA uptake
measurements were described in our previous work [56]. The electric current measured
during the in vivo experiments provides the information about the bulk tissue conduct-
ivity changes during the pulse delivery.
In order to compare and evaluate the results of our numerical models to the experi-
mental data we calculated the goodness-of-fit measure R2 between numerically calcu-
lated and in vivo measured electric current I [A] at the end of the last delivered pulse
(i.e. the 8-th pulse) to the tissue.Numerical modeling
Electric field distribution in the models of tissue exposed to electroporation pulses U
[V] can be determined by solving the equation (Eq. 1) for scalar electric potential.
Namely, if we neglect the capacitive transient and time course of conductivity increase
Corovic et al. BioMedical Engineering OnLine 2013, 12:16 Page 5 of 27
http://www.biomedical-engineering-online.com/content/12/1/16during the pulse, we may assume that the current density in tissue is divergence free
and electric potential satisfies:
 ∇⋅ σ⋅∇φð Þ ¼ 0 ð1Þ
where σ and φ represent tissue conductivity [S/m] and electric potential [V], respectively.
Applied voltage (model input) was modeled as Dirichlet’s boundary condition on the
contact surface between electrode and tissue geometry. For the model input values we
used the amplitudes of the electroporation pulses applied in vivo [56]. In order to
mathematically separate the conductive segment from its surroundings we applied
Neuman’s boundary condition (Jn = 0, where Jn is the normal electric current density
[A/m2]) on all outer boundaries of our models.
As long as the applied voltage U [V] is low enough the tissue conductivity σ [S/m]
can be treated as a constant (i.e. σ = const. in Eq. 1), the problem is therefore described
by the Laplace’s equation which is a linear partial differential equation that can be easily
solved numerically. In this case the tissues can be modeled as a linear conductor with
linear current–voltage I(U) relationships due to the constant tissue conductivities since
the amplitude of the applied electroporation pulses is too low to produce an E above
the reversible electroporation threshold (E < Erev).
However, to account for experimentally observed tissue conductivity increase due to elec-
troporation, Eq. 1 becomes nonlinear partial equation as σ is no longer constant. If the local
electric field in the tissues exceeds the Erev value, electric properties of treated tissue change
(i.e. tissue conductivity increases due to the electroporation process). In this case the σ in
Eq.1 depends on the electric field intensity E: σ = σ(E). Namely, during the application of
electroporation pulses, tissue conductivity increases according to the functional dependency
of the tissue conductivity on the local electric field distribution σ(E), which in our study de-
scribes the dynamics of the electroporation process. This subsequently results in nonlinear
electric current voltage relationship I(U) (i.e. numerical model of tissue is non-linear).
Measurement of electric current I [A] during delivery of eight rectangular electropor-
ation pulses of 100 μs duration and 1 Hz repetition showed that after rapid capacitive
transient (which is due to tissue capacitance) the current increased towards the end of
the pulse [56,52]. The rate of increase of electric current I [A] depends on the applied
voltage U [V], which provides information about the changes in electric properties of
the treated tissue (i.e. changes in electric conductivity of the tissue σ [S/m]). The rates
of increase of I and σ thus allow us to identify the degree of tissue electroporation.
Numerical calculations of Eq.1 and tissue electroporation dynamics σ(E) in our study
were performed with three different approaches that were based on finite element
method: Inverse analysis (IA), nonlinear parametric analysis (NPA) and sequential ana-
lysis (SA). The software for IA was previously developed by Center for Computational
Continuum Mechanics (Ljubljana, Slovenia) [61], while for the NPA and the SA we
used Comsol Multiphysics software (version 3.5a, COMSOL, Sweden).
The three abovementioned modeling approaches are described here below:
Inverse analysis (IA)
The IA is based on standard Newton–Raphson method, which is widely used for calcu-
lating nonlinear problems based on finite element method. The tissue electroporation
dynamics i.e. the dependence of the electrical conductivity with respect to electrical
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ters of these relationships are calculated by IA [60]. The IA is performed by using a sym-
bolic system AceGen (Multi-language, Multi-environment Numerical Code Generation)
[64] with AceFeM environment (The Mathematica Finite Element Environment) [65] for
development of finite element equations and generation of corresponding finite element
user subroutines. This enables symbolic formulation of the problem at a high abstract
level. The derivation presented here follows a general approach to the automation of pri-
mal and sensitivity analysis of transient problems introduced by [66]. Below is a brief de-
scription of the formulation.
The response of the steady-state non-linear problem is defined by the global residual
vector R and the vector of unknown variables of the problem φ (Eq. 2):
R φð Þ ¼ 
X
e
Re φð Þ ¼ 0 ð2Þ
where Re represents the contribution of the e-th element to the global residual and e is
the element number. The operator *Σ is chosen here instead of the ordinary Σ symbol in
order to denote that an assembly process takes place in which all element contributions
have not only to be added up but also the kinematical compatibility between the elements
has to be fulfilled [60]. The residual vector R is a part of standard notation used in finite
element analysis. The finite element problems are represented by a set of equations in the
residual form, which are solved iteratively using the Newton–Raphson method. The sys-
tem given by the Eq. 2 can therefore be solved by the Newton–Raphson method, in which





Δφ ¼ R φ ið Þ
 
ð3Þ
φ iþ1ð Þ ¼ φ ið Þ þ Δφ ð4Þ
The terms R(φ(i)) and dR φ ið Þ
 
are referred to as the residual (or load) vector and thedφ
tangent operator (or tangential stiffness matrix), respectively. The independent solution
vector φ(i) is updated after the linear system given by the Eq. 3 has been solved for the
unknown increment Δφ. The upper index (i) refers to the quantities at the i-th iteration
step of the outer loop.
The distribution of static electric field is determined by solving the Eq. 1. By using in-






J :nδφdS ¼ 0 ð5Þ
where φ is the electric potential,V is volume, S is surface and J is current density.
Discretization of Eq. 5 by φ =Ne. φe and δφ =Ne. δφe =Ne leads to the Eq. 6:
Re φð Þ ¼
Z
Ve





where φ is the electric potential, φe are the electrical potentials in the element nodes, δφ
is the test function, Ne are the nodal shape functions and σ is the electrical conductivity.
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ivity σ with respect to electric field strength E as follows:
σ Eð Þ ¼ σ0 þ kσ Eð Þ I ð7Þ
σ Eð Þ ¼ σ0 þ c1 ec2 E  1
  
I ð8Þ
where electric field strength E is defined as:
E ¼ ∇φ
E ¼ ﬃﬃﬃﬃﬃﬃﬃE:Ep ð9Þ
and I is the identity matrix. The constant in Eq. 7 and Eq. 8 stands for the baseline tis-
sue conductivity of non-electroporated tissue (i.e. σ0 = σ(0)), while the constants kσ, c1
and c2 stand for the parameters of linear (Eq. 7) and exponential (Eq. 8) functions de-
scribing electroporated tissue (i.e.σ(E)).
Unknown coefficients σ0, kσ, c1 and c2 were determined with IA [60] by minimizing
the objective function f of the following form:








Determination of unknown coefficients σ0, kσ, c1 and c2 allowed us to detect theproperties of the treated tissue for both situations σ = const. (i.e. σ0 = σ(0)) and σ(E)).
By using the Newton's method in the Mathematica (version 8.0) programming envir-
onment the minimization problem is defined as:
g x ¼ σ0; kσ ; c1; c2f gð Þ ¼























































where U is the voltage between the electrodes, IFEM is the calculated current and






and ∂IFEM∂c2 were calculated within the finite element method analysis.
Nonlinear parametric analysis (NPA)
The NPA has been developed in our previous study [62]. In the present study we
used NPA to solve the equation Eq. 1 for both conditions σ = const. (for E < Erev) and
σ = σ(E) (for E ≥ Erev) by using Comsol Multiphysics’ stationary nonlinear solver.
Namely, we treat the problem as stationary since we analyzed the tissue behavior by
calculating the σ(E) dependency at the end of the applied pulse U [V]. The parame-
ters defined by NPA are the values of the applied voltages U (i.e. model inputs). The
electric current I [A] is calculated as a model output providing the value of I [A] at
the end of pulse. The Comsol Multiphysics’ nonlinear solver uses an affine invariant
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dependent variable U (i.e. U0). Starting with the initial guess, the software forms the
linearized model using U0 as the linearization point i.e. the discrete form of the
equations as f(U) = 0, where f(U) is the residual vector and U is the solution vector.
The iterative Newton method can be applied in the usual way, expanding the re-
sidual vector in a Taylor series, neglecting all but the first order term. The software
solves the discretized form of the linearized model f ’(U0)δU = −f(U0) for the Newton
step δU by using the selected linear system solver (the f ’(U0) is the Jacobian matrix).
It then computes the new iterate U1 = U0 + λδU, where λ is the damping factor. The
modified Newton correction then estimates the error Eerror for the new iterate U1 by
solving f ’(U0)Eerror = −f(U1). If the relative error corresponding to E is larger than the
relative error in the previous iteration, the code reduces the damping factor λ and
recomputes U1. This algorithm repeats the damping-factor reduction until the relative
error is less than in the previous iteration or until the damping factor underflows the
minimum damping factor. When it has taken a successful step U1, the algorithm proceeds
with the next Newton iteration. A value of λ = 1 results in Newton’s method, which con-
verges quadratically if the initial guess U0 is sufficiently close to the solution. Comsol
Multiphysics will reduce the damping factor and re-compute U1 if the relative error is lar-
ger than the previous value. The purpose of this damping factor is to make the process
converge for a broader range of initial values (initial guesses U0).
It is necessary to increase the voltage U from 0 V in small steps and use the solution
from a previous step as the initial condition for the next step. This is taken care of
automatically by the parametric solver. The parametric solver consists of a loop around
the stationary solver. If the nonlinear solver does not converge it tries a smaller param-
eter step; if it does converge it determines the size of the next parameter step based on
the speed of the convergence of the Newton iteration.
Sequential analysis (SA)
The SA in our study was based on the sequential permeabilization model proposed by
[58], where changes in tissue conductivity were used as an indicator of tissue
permeabilization. Namely, the dynamics of electroporation was modeled as a discrete
process with the sequence of static finite element models. Each of the finite element
models described the process in one discrete interval (each of the discrete intervals re-
lates to a real, discrete, but undetermined time interval). In each static finite element
model in sequence, the tissue conductivity was determined based on the electric field
distribution from the previous model in the sequence according to the Eq. 12:
σ kð Þ ¼ f E k  1ð Þð Þ ð12Þ
where k stands for the number of static finite element models in sequence.
Model input is the applied voltage pulse, and model outputs are the electric field dis-
tribution E and total electric current I in each specific sequence k. The increase in elec-
trical current I from I0 to Ik simulates the tissue response during the delivery of the
electroporation pulses U in each discrete interval k (static finite element model in se-
quence) to the tissue electroporation (i.e. due to the functional dependency of σ on the
electric field distribution E). If the electroporation does not occur, σ remains constant,
thus I = I0. More detailed description of SA is given in [16,58,59].
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3.5a software package were performed in the 3D Conductive Media DC application mode
on a computer running Windows XP (64 bit) with a 3.00 GHz Intel Pentium D processor
and 2 GB of RAM.
For the numerical calculations with IA we used AceGen (version AceFEM 3.101) sys-
tem [61,64,65]. The calculations were performed on a computer running Windows XP
(64 bit) with 2.67 GHz Intel Core i7 CPU and 6 GB of RAM.
Results of numerically calculated model outputs (such as total current and local elec-
tric field distribution) with all three approaches were controlled for numerical errors by
increasing the mesh density until the output results changed by less that 0.5%. The
mesh of the resulting finite element models of liver tissue electroporated with plate and
needle electrodes were composed of approximately 30 000 and 25 400 elements, re-
spectively. Number of generated finite elements of the tumor mesh model was 30 268.Model geometry and electric properties of a single tissue
The 3D geometry of the numerical model and its 2D cross-sectional view in XY plane
of a single tissue (i.e. liver tissue) is given in Figure 1. The model of liver tissue
electroporated with plate electrodes is given in Figure 1A, while the model of liver tis-
sue electroporated with a pair of needle electrodes is given in Figure 1B.
By using the IA numerical simulations we identified both baseline electric conductiv-
ity of tissue σ0 (for the condition σ(0)) and linear and exponential σ(E) (Eqs. 7 and 8)
that fitted best the experimental data in vivo [56]. The determined σ0 and σ(E) for plate
and needle electrodes were then compared to the data from the literature.Figure 1 Geometry of numerical models of liver tissue. A. treated with plate electrodes and B. treated
with needle electrodes. The parameter σL stands for the conductivity σ [S/m] of liver tissue.
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increase factor due to electroporation, the reversible and ireversible threshold values
(Erev and Eirrev) to be predefined, in our models we selected the data from [58,62,67,68].
The functional dependencies σ(E) predefined in the models were sigmoid-like func-
tion implemented as smoothed Heaviside's step function [62] with continuous sec-
ond derivative and sigmoid function σ(E) that was implemented by Sel and
colleagues [58].Model geometry and electric properties of composite tissue
The geometry of composite tissue i.e. subcutaneous tumor is shown in Figure 2A. The
distance between two plate electrodes used in experiments was d = 5.2 mm. The tumor
geometry was created so as to match as accurate as possible the electrode placement
and the geometry of the tissue treated within the in vivo experiments. The electrodes
in Figure 2A only sketch the site of electrodes’ position in the experiments and do not
take part of the numerical model. The body of the electrodes was not modeled in our
numerical model in order to reduce the computation time of numerical simulations.
The electrodes were modeled rather as boundary conditions defined on the electrode-
tissue contact surfaces (Figure 2B).
The numerical model of the tumor was built as a heterogeneous 3D model composed
of four types of tissues with different electric properties (i.e. electric conductivities).
The skin in our subcutaneous tumor model was modeled as two-layer tissue: the first
layer comprised the electric properties of stratum corneum and epidermis (σSE), while
the second layer comprised dermis and fat tissue (σDF). The underlying muscle tissue
was modeled as anisotropic tissue with σM⊥ (Y and Z direction -Figure 2) and σM|| (X
direction - Figure 2) in perpendicular and parallel direction of E with respect to the
muscle fibers. The baseline conductivities of the modeled tissues (i.e. the initial σ of
non-electroporated tissues for E < Erev), the conductivity increase factor due to tissue
electroporation and the threshold values Erev and Eirrev for each of the tissues were se-
lected based on data we published previously [9,16,59,69]and based on the comparisonFigure 2 Geometry of numerical model of subcutaneous tumor. A. The geometry dimensions and
composition of cutaneous tumor model. (The electrodes in this figure only sketch the site of electrodes’
position in the experiments and do not take part of the numerical model) and B. 3D geometry of tumor
model with the contact surface between tissue and electrodes. The distance between plate electrodes
was d = 5.2 mm.
Corovic et al. BioMedical Engineering OnLine 2013, 12:16 Page 11 of 27
http://www.biomedical-engineering-online.com/content/12/1/16of I [A] calculated in our models to the in vivo measurements. Our numerical and ex-
perimental analysis was performed for two different types of cutaneous tumors: B16
melanoma and LPB sarcoma.
The relationship of electric conductivity with respect to the local electric field σ(E)
for all modeled tissues was considered to be smoothed Heaviside step function taking
into account the electric conductivities and the threshold values data listed in Table 1.
For the numerical calculations we used NPA. We examined the electric current and
local electric field distribution within the model of subcutaneous tumor for three differ-
ent electric properties of target tumor tissue σT1, and σT2 and σT3.
Statistical analysis
To compare the outputs of our models to the experimentally measured data we calcu-
lated coefficient of determination R2, which represents a statistical measure of how well
the model data approximates the real data points (i.e. the measure of the goodness-of
-fit between the modeled and measured data). The R2 = 1 means that the model data
perfectly fit the real data points. If the R2 has a value closer to the 0 or a negative value
the model data do not fit the real data points.
The coefficient of determination is given by the Eq.13.
R2 ¼ 1 SSerr
SStot
ð13Þ
where SSerr and SStot are residual sum of squares and the total sum of squares,
respectively.
The "variability" of the data set is measured through the sums of squares SSerr and
SStot.




yi  fið Þ2 ð14Þ
where yi data stand for the measured values of electric current at the end of the pulse,
each of which has an associated modeled value fi.Table 1 The defined parameters of tissues composing the subcutaneous tumor model
Tissue Erev [V/cm] Eirrev [V/cm] Initial σ for E < Erev σ increase for
E > Eirrev vs E < Erev
Stratum corneum
and epidermis
400 1200 σSE = 0.008 S/m 100
Dermis and fat 300 1200 σDF = 0.25 S/m 4
Tumor 400 800 σT1 = 0.3 S/m 2.5
σT2 = 0.6 S/m
σT3 = 0.9 S/m
Muscle transversal 200 800 σM⊥ = 0.135 S/m 2.5
Muscle longitudinal 80 800 σM|| = 0.75 S/m 2.5
The baseline conductivities σ of modeled tissues, reversible and irreversible threshold values (Erev and Eirrev) of the tissues
and the rate of increase in tissue conductivity due to electroporation. The relationship σ (E) for all tissues was smoothed
Heaviside function.
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Modeling of electric field distribution during electroporation with plate electrodes was
performed with IA and with NPA for the model geometry given in Figure 1A. The
geometry details are identical as in in vivo experiments [56] and in our previous work
where the NPA was first implemented [62].
By using IA we first identified linear and exponential relationship σ(E) (Eqs. 7 and 8)
and determined corresponding baseline tissue conductivity σ(0) (Figure 3A).
The calculated I(U) and G(U) for both identified relationships σ(E) (linear and expo-
nential) by means of IA are shown in Figure 4. In Figure 4 the I(U) and G(U) character-
istics with σ(E) were also compared to the corresponding I(U) and G(U) obtained in
the model with constant electric conductivity (i.e. with baseline tissue conductivities:
σ = const. = 0.093 S/m and σ = const. = 0.088 S/m).
We then performed numerical modeling with NPA with smoothed Heaviside rela-
tionships of σ(E) for two predefined baseline electrical conductivities: 0.126 S/m [67]
and 0.091 S/m [68]. Within the smoothed Heaviside relationships of σ(E) the conduct-
ivity increase factor was chosen to increase by factor of two and three [62] which is in
agreement with previously experimentally observed σ increase at the end of pulse [2]
For the reversible and irreversible threshold values we have chosen 200 V/cm and
1000 V/cm, respectively [62]. The examined smoothed Heaviside relationships σ(E)
with corresponding baseline conductivities and the conductivity increase factors are
shown in Figure 3B.
The obtained I(U) and G(U) characteristics in the models with relationships σ(E) and
constant σ (from Figure 3B) are shown in Figure 5A and B, respectively.
Calculated goodness of fit R2 measure for the results obtained with IA and NPA are
given in Tables 2 and 3, respectively. Almost identical fit was obtained for exponential
and linear σL(E) relationship with IA (Table 2). The results of NPA performed in the
model with smoothed Heaviside relationship σL(E) and baseline conductivity 0.126 S/m
better fitted the experimental data when the conductivity increase factor was chosen to
increase by a factor of two - σL1(E), while the model with baseline conductivity 0.093 S/m
better fitted the experimental data when the conductivity increase factor was chosen to
increase by a factor of three - σL2(E), Table 3.
Figure 3 Baseline conductivities (σL(E) = σ0 = const.) and tissue conductivity vs. electric field
dependencies σL(E). A. σ0 and σL(E) identified by using IA and B. σ0 and σL(E) predefined in our numerical
models based on the data from literature – smoothed Heaviside σL(E) was predefined for the numerical
calculations with NPA. σL1(E) and σL2(E) stand for the smoothed Heaviside relationships σL(E) with
conductivity increase factor (due to electroporatoion) of two and three, respectively.
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In order to identify the baseline liver conductivity and functional dependency of the tis-
sue conductivity on local electric field σ(E) we first performed numerical modeling by
using inverse analysis IA on a set of experimental data obtained with needle electrodes
with diameter 0.7 mm (Figure 6B). The identified relationship σ(E) was determined to
be linear with baseline liver conductivity σ0 = 0.046 S/m (Figure 7B). In order to verify
the identified parameters of IA we further implemented the same identified relationship
on sets of experimental data obtained with needle electrodes with diameters: 0.3 mm,
and 1.1 mm, given in Figure 6A and C, respectively and calculated the goodness of fit
measure R2 for all three models (Table 4). The numerically calculated I(U) relationship
taking into account the linear relationship σ(E) was compared to the I(U) with σ = con-
stant corresponding to the identified baseline tissue conductivity (σ = const. =
0.046 S/m) (Figure 6A, B and C).
In order to compare the results of NPA and SA to the experimental data we also cal-
culated I(U) relationships for predefined relationships σ(E): smoothed Heaviside with
NPA and sigmoid with NPA and SA (Figure 7B). We predefined the baseline liver
Figure 4 Comparison of numerical simulations performed with IA to the data measured in vivo. A.
Electric current vs. voltage relationships I(U) calculated in nonlinear models (with linear and exponential σL
(E)), calculated in linear models (with σL(E) = σ0 = const.) and measured in vivo and B. Conductance vs.
voltage relationships G(U) calculated in nonlinear models (with linear and exponential σL(E)), calculated in
linear models (with σL(E) = σ0 = const.) and measured in vivo.
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data by Sel and colleagues [58,54]: σL0 = 0.067 S/m, Erev = 460 V/cm and Eirrev = 700
V/cm. The NPA and SA were also performed for tissue model with needle electrodes
of 1.1 mm diameter given in Figure 1B. Our model corresponds to the one used in [58]
in which the SA-analysis was first developed and implemented. The I(U) relationships
obtained with σ(E) were compared to the models with constant σ (i.e. σ = 0.067 S/m
and σ = 0.046 S/m), Figure 7.
Comparison of U(I) characteristics obtained in the model (needle electrodes, diam-
eter 1.1 mm) with relationships σ(E) and σ = const. to the experimental data by using
IA, NPA and SA is shown in Figure 7.
Calculated goodness of fit measure R2 for models with needle electrodes obtained
with all three different analyses is given in Table 4.
By using SA analysis we calculated the I(U) characteristics for two different
discretizations of modeled pulses: 5 steps and 15 steps. In Figure 7 we showed only the
I(U) for 5 discretization steps since the goodness-of-fit for I(U) obtained with 15 steps
Figure 5 Comparison of numerical simulations performed with NPA to the data measured in vivo.
A. Electric current vs. voltage relationships I(U) calculated in nonlinear models (with linear and exponential
σL(E)), calculated in linear models (with σL(E) = σ0 = const.) and measured in vivo and B. Conductance vs.
voltage relationships G(U) calculated in nonlinear models (with linear and exponential σL(E)), calculated in
linear models (with σL(E) = σ0 = const.) and measured in vivo.
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(15 steps) vs. R2 = 0.8938 (5 steps), Table 4.
The dashed green curve and the solid green curve in the Figure 7A represent the I
(U) relationships obtained with SA and NPA, respectively. In both analyses the same
σ(E) was used (i.e. sigmoid function represented with green solid curve in Figure 7B).
The difference between the two I(U) relationships occurs due to the different discretisationTable 2 Calculated R2 between IA and in vivo data – plate electrodes
Linear model with σL = const. Nonlinear model with σL(E)
σL(0) = 0.093 S/m Exponential σL(E)
R2: 0.1297 0.7995
σL(0) = 0.088 S/m Linear σL(E)
R2: 0.1295 0.7993
The calculated goodness-of-fit measure R2 between numerical data obtained with linear model (i.e. model with
σL = const.) and nonlinear model (i.e. model with σL(E)) (i.e. model with and in vivo data.
Table 3 Calculated R2 between NPA and in vivo data – plate electrodes
Linear model with σL = const. Nonlinear model with smoothed Heaviside σL(E)
σL = 0.126 S/m σL1(E) σL2(E)
R2: 0.5637 0.7997 0.4538
σL = 0.091 S/m σL1(E) σL2(E)
R2: 0.1296 0.6203 0.7838
The calculated goodness-of-fit measure R2 between numerical data obtained with linear model (i.e. model with
σL = const.) and nonlinear model (i.e. model with σL(E)) and in vivo data. σL1(E) and σL2(E) stand for the smoothed
Heaviside relationships σL(E) with conductivity increase factor (due to electroporatoion) of two and three, respectively.
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cretisation of σ(E) is obtained by employing 5 step functions) compared to finer automatic
discretization of σ(E) used in NPA.Composite tissue
The comparison of numerically calculated total current I [A] in tumor models (with
σ(E) and σ = const. given in Table 1) to the total current measured in vivo for two dif-
ferent types of tumors B16 melanoma and LPB sarcoma is given in Figure 8A and B, re-
spectively. The examined σT(E) are shown in Figure 9B.
The calculated goodness of fit R2 for two different types of tumors B16 melanoma
and LPB sarcoma is given in Table 5.
The calculated volume fraction (i.e. volume percentage V [%]) of the target tumor tis-
sue exposed to the local the electric field distribution above Erev and Eirrev for three dif-
ferent σ(E) relationships of target tumor tissue (i.e. σT1(E), σT2(E) and σT3(E)) and for σ
independent of E (i.e. σT = const.), is presented in Figure 9. The entire volume of the
target tumor tissue (VT_E>Erev = 100%) was exposed to the local electric field above Erev
at different applied voltages for different target tumor tissue conductivities σT(E): U =
340 V (for σT1(E)), U = 400 V (for σT2(E)) and U = 440 V (for σT3(E)). The exposure of
the target tumor tissue to the E above irreversible threshold value VT_E > Eirrev was also
obtained for different U for different σT(E): VT_E >Eirrev = 100% for σT1(E) was obtained
at U = 720 V Figure 9A, while the VT_E >Eirrev =100% for σT2(E) and σT3(E) was
obtained for U > 800 V (in our study the U was applied from 20 V to 800 V).
The volume of the target tumor tissue VT in the subcutaneous model with constant
conductivities of all tissue σSE, σDF, σM⊥ and σM|| and σT = const. was zero (VT_E>Erev = 0)
as shown in Figure 9A.
We visualized the calculated local electric field distribution within the model of sub-
cutaneous tumor tissue for two different applied voltages U = 176 V and U = 276 V
(Figure 10) in XY cross-section plane (see Figure 2). At the applied voltage U = 176 V
the local electric field in the target tumor tissue just started to enter the tumor, while
the U = 276 V was chosen to show the difference in distribution of E for different elec-
tric properties of the target tumor tissue σT(E).
The electric field distribution is calculated for four different conductivities of target
tumor tissue σT: Figure 10A σT = const., Figure 10B σT1(E), Figure 10C σT2(E) and
Figure 10D σT3(E). The electric field distribution in Figure 10 was displayed in the
range from the reversible Erev and irreversible threshold value Eirrev of the target tumor
tissue 400 V/cm ≤ E ≤ 800 V/cm.
Figure 6 Comparison of numerical simulations performed by IA to the data measured in vivo.
Electric current vs. voltage relationships I(U) calculated in nonlinear models (with linear and exponential σL
(E)), calculated in linear models (with σL(E) = σ0 = const.) and measured in vivo by using needle electrodes
with diameters: A. 0.3 mm, B. 0.7 mm and C. 1.1 mm.
Corovic et al. BioMedical Engineering OnLine 2013, 12:16 Page 17 of 27
http://www.biomedical-engineering-online.com/content/12/1/16
Figure 7 Comparison of numerical simulations performed by IA, NPA and SA to the data measured
in vivo. A. Comparison of U(I) characteristics calculated in nonlinear model and linear to the in vivo data.
B. The relationships σL(E) and constant conductivities σL(E) = σ0 = const. in nonlinear and linear models,
respectively. The diameter of needle electrodes was 1.1 mm.
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In a recent study of robustness of electrochemotherapy treatment planning based on
analysis of local electric field distribution E the authors show that the uncertainties in
predefined dielectric properties of the treated tissues and in the rate of increase in elec-
tric conductivity due to the electroporation have large effect on treatment effectiveness,
which indicated that more experimental and numerical research is needed [43]. Numer-
ous other numerical and experimental studies also showed that the electric conductivityTable 4 Calculated R2 between IA, NPA and SA and in vivo data - needle electrodes
Electrode diameter
1.1 mm 0.7 mm 0.3 mm
Analysis type with σL(E) R2:
IA with linear σL(E) 0.883214 0.875605 0.92873
NPA with smoothed Heaviside σL(E) 0.9192
NPA with sigmoid σL(E) 0.8964
SA with sigmoid σL(E): 0.8938
* The calculated R2 for SA is given for the σL(E) with 5 discretization steps. The calculated R
2 for models with σ being
independent of E (σL = const. = 0.04593 S/m and σL = const. = 0.067 S/m) was negative.
The calculated goodness-of-fit measure R2 between numerical data obtained with nonlinear model (model with σL(E))
and in vivo data.
Figure 8 Numerically calculated vs. in vivo measured I(U) relationship in subcutaneous tumors.
Comparison of numerically calculated I [A] (in both nonlinear and linear models) with the experimentally
measured I [A] for two types of tumors: A. B16 melanoma and B. LPB sarcoma. In nonlinear numerical
models we examined three different σL(E) of tumors (Table 1 and Figure 9b).
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ies the electroporated tissues are often considered as conductive materials with con-
stant electric conductivities.
In our study we therefore investigated whether the functional dependency of electric
properties and of local electric field distribution within treated tissues need to be taken
into account when modeling tissue response to the electroporation pulses.
We compared linear (i.e. tissue conductivity is constant σ = const.) and non-linear
model (tissue conductivity depends on local electric field σ(E)) to the experimental data
in vivo [56]. We built our numerical models so as to fit as accurately as possible the tis-
sue geometry, the electrode geometry and the contact surface between the electrodes
and tissue treated in in vivo experiments. In the first part of our study we performed
the comparison for single tissue (i.e. one type of tissue) for two types of electrodes:
plate and needle electrodes. For single tissue modeling we analyzed the experimental
data performed in rat liver treated with plate electrodes and in rabbit liver treated with
needle electrodes (Figure 1).
Figure 9 Reversibly and irreversibly electroporated tumor volume VT [%] in linear (σT(E) = const.)
and nonlinear models (σT (E)). A. The calculated percentage of tumor volume VT [%] exposed to the local
electric field above Erev and Eirrev and B. the examined baseline conductivities (σT(E) = const.) and
relationships σT(E) of the target tumor tissue.
Corovic et al. BioMedical Engineering OnLine 2013, 12:16 Page 20 of 27
http://www.biomedical-engineering-online.com/content/12/1/16The main findings of the single tissue analysis were then applied to the model of
composite tissue (i.e. the tissue composed of different types of tissues with different
electric conductivities). The study of composite tissue was performed for subcutaneous
tumor that consisted of stratum corneum, dermis, epidermis, connective and fatty tis-
sue, tumor tissue and muscle tissue and was treated with plate electrodes (Figure 2).
Numerical simulations in our study were performed by using three different model-
ing approaches: IA [60,61], NPA [62] and SA [58].Table 5 Calculated R2 between model data and in vivo data (plate electrodes, NPA)





* Subcutaneous tumor models with σ being independent of E (i.e. σT, σSE, σDF, σM⊥, σM|| = const.) have negative R
2.
The calculated goodness-of-fit measure R2 between numerical data obtained with nonlinear model (i.e. model with σ(E))
and in vivo data obtained for B16 melanoma and LPB sarcoma.
Figure 10 Local electric field E in the numerical model of subcutaneous tumor. Calculated and
visualized local electric field E distribution for two different applied voltages U = 176 V and U = 276 V in XY
cross section plane of the subcutaneous tumor model. The E is calculated for the following σT of the target
tumor: A. σT = const., B. σT1(E), C. σT2(E) and D. σT3(E).
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single tissue (i.e. rat liver tissue) treated with plate electrodes. The relationship between
local electric field distribution and the conductivity of liver tissue σ(E) was described by
linear (Eq. 7) and exponential functions (Eq. 8). The parameters of these two functions
(parameters σ0 and kσ of linear function and parameters σ0, c1 and c2 of exponential
function) were than calculated with IA-analysis algorithm by fitting the data of numer-
ically calculated to the experimentally measured values of total electric current flowing
through the tissue (Figure 3). The parameters σ0 in both functions σ(E) (linear and ex-
ponential) represented the baseline tissue conductivities for the condition σ0 = σ(0))
(i.e. the initial conductivity of non-electroporated tissue). We calculated these parameters
to be σ0 = 0.088145 S/m (linear function Eq. 7) and σ0 = 0.092768 S/m (exponential func-
tion Eq. 8). The numerically calculated values of σ0 of both functions correspond well to
the measured conductivities of rat liver tissue published by Gabriel and colleagues [68].
These results show that the IA allows for identification of the initial tissue conductivity
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the electroporation pulses. In order to compare the numerical models of liver tissue that
consider exponential and linear σ(E) relationship to the numerical model with constant
conductivity (σ(E) = const.) we used the calculated data σ0 for development of the models
with constant conductivities: σ(E) = σ0 = const. The calculation of goodness of fit measure
(R2) of the numerical models that take into account the relationship σ(E) fit better experi-
mental data compared to the models with constant conductivity: linear σ(E) R2 = 0.7993
and exponential σ(E) R2 = 0.7995 vs. σ(E) = σ0 = 0.088145 S/m = const. R
2 = 0.1295 and
σ(E) = σ0 = 0.092768 S/m = const. R
2 = 0.1297 (Table 2)). These results show that the IA
also allows for identification of functional dependency of tissue conductivity σ(E) of the
electroporated tissue. The results of our study thus demonstrate that by using IA both the
baseline electric conductivity for non-electroporated tissue (for the condition σ(0) = const.
for E = 0 or E < Erev) and the σ(E) relationship of the tissue exposed to U that results in tis-
sue electroporation (E > Erev) can be identified.
The calculation of tissue conductance G [S] show that the conductance of the models
with σ(E) increased with increase of the applied voltage following the measured data of
G Figure 3D. We can observe that the models G = const. do not describe the electro-
poration process of the tissue which is in agreement with our previous findings [2,56],
as well as recent multiscale modeling [57].
In order to compare numerical simulations obtained by nonlinear parametric analysis
(NPA) to the numerical simulations obtained with inverse analysis (IA) we used the
same geometry of liver tissue and electrodes (Figure 1A) and electric properties of tis-
sue (σL0 = const. and σ(E)) as used in our previous work [62]. Namely, for the initial pa-
rameters of tissue conductivity we used two different measured values from the
literature σL0 = 0.091 S/m (pig liver) [68] and σL0 = 0.124 S/m (rat liver) [67]. The rela-
tionship between the local electric field and tissue conductivity σ(E) was implemented
to the tissue model as smoothed Heaviside’s function. The numerical calculations were
performed for both constant conductivity σ = const. and σ(E) with conductivity increase
factor of two and three (Figure 3B), which is in agreement with experimentally mea-
sured conductivity increase at the end of the pulse [2,58]. Our results show that the nu-
merical models with σ(E) better fit experimental data than models with σ = const.
(Table 3). Numerical model with initial conductivity of rat liver better fit experimental
data for the conductivity increase factor of two (R2 = 0.7997), the numerical model with
initial conductivity of pig liver better fit experimental data for the conductivity increase
factor of three (R2 = 0.7838). When comparing the numerical results obtained with
NPA to the results obtained with IA we can conclude that similar results and good
agreement between numerical and experimental data can be obtained with both model-
ing approaches when σ(E) relationship is taken into account (regardless of the shape of
the σ(E)). Both approaches show that the models with σ(E) fit the measured data con-
siderably better than models with constant conductivity. However, more precise mea-
surements are needed for determination of the shape of the σ(E) function that might be
tissue type specific.
In the second part of our study we built numerical models of single tissue (rabbit
liver) treated with needle electrodes of three different diameters 0.3 mm, 0.7 mm and
1.1, that were used also in in vivo experiments. By using IA we first identified the σ(E)
for the tissue model with needle electrodes with diameter of 0.7 mm, as in this case we
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numerical data with experimental data was obtained with linear σ(E) function (Figure 6B)
with R2 = 0.875605 (Table 3). The identified value of the initial tissue conductivity was σ0 =
0.04593 S/m which correspond to the measured conductivity of rabbit liver (summarized in
[58]). The identified linear function in the model with 0.7 mm was then applied to the
models with 0.3 mm and 1.1 mm and good agreement between calculated data were
obtained R2 = 0.92873 (for 0.3 mm) and R2 = 0.883214 (for 1.1 mm) (Table 4).
For the model with electrode diameter 1.1 mm we also performed NPA with
smoothed Heaviside and sigmoid σ (E) function and sequential analysis with sigmoid
function σ(E) with parameters determined by [58]. We also performed numerical ana-
lysis with σ(E) = const. The comparison of the model with σ(E) = const. to the numer-
ical models with σ(E) showed that models with σ(E) fit experimental data considerably
better then models with σ(E) = const. (Table 4). When comparing numerical results of
different modeling approaches (Figure 7) we further observed that the best fit between
the numerical and experimental data was obtained with NPA with smoothed
Heaviside’s function R2 = 0.9192 (Table 4).
Based on the comparison of all three modeling approaches validated with experimen-
tal measurements we determined the important advantages for electroporation process
modeling of each of the approaches. Namely, the IA can be used as a modeling ap-
proach for the situations when the conductivity of treated tissue is difficult to be mea-
sured before or during electroporation. The NPA allows for parametric analysis of
electric current at the end of the applied voltage pulses while the SA allows also an
insight into the electroporation process (i.e. the course of σ(E) changes) during the ap-
plied pulse. Although, the NPA and SA modeling approaches require the baseline con-
ductivity and the σ(E) need to be predefined, the important advantage is that these two
modeling approaches are relatively simple to be used in commercial software which is
accessible and widely used.
In the third part of our study we built the numerical model of subcutaneous tumor
in order to examine the influence of tissue heterogeneity on the electric field distribu-
tion during electroporation of a composite tissue (i.e. tumor model composed of differ-
ent types of tissues). We compared the numerical calculation of total electric current in
the tumor model with constant conductivity of all constituent tissues and the numerical
calculation of total electric current in the tumor model that took into account σ(E) of
all involved tissues to the experimental measurements in vivo carried out in two differ-
ent types of tumors: B16 melanoma (Figure 8A) and LPB sarcoma (Figure 8B). For all
tissues in the model we implemented smoothed Heaviside’s function σ(E).
Based on the comparison of the numerical and experimental data in vivo we demon-
strated that the model that took into account σ(E) of all involved tissues fits better
in vivo data than model with constant conductivities (Table 5). Our results further
show that the subcutaneous tumor model with higher conductivity of target tumor tis-
sue σT3(E) fits better the in vivo data of B16 melanoma while the model with σT1(E)
better fits the in vivo data of LPB sarcoma subcutaneous tumor (Table 5), suggesting
that B16 melanoma has higher conductivity than LBP sarcoma. The visualization of
local E in the subcutaneous tumor model demonstrates that the more conductive the target
tumor tissue the higher the intensity of E in the surrounding tissue and the lower E in the
tumor tissue (Figure 10A and B), which is in agreement with our previous findings [70].
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and Eirrev (Figure 9A) and demonstrated that more conductive target tumor tissue were
more difficult to be successfully electroporated, since they require higher voltage U to
be applied to the electrodes in order to expose the entire volume of the target tumor
above the Erev or higher, which also results in higher intensity of E in the skin and
muscle and subsequently may induce more damage to the surrounding healthy tissue
(Figure 10). We also demonstrated that the electroporation of more conductive tissues
resulted in higher values of total electric current I [A] flowing through tissue (Figure 8).
The exposure of the target tumor tissue to the E above irreversible threshold value also
depends on the electric properties of the target tumor tissue σT(E). It needs to be em-
phasized that the subcutaneous model with constant conductivities of all tissues (i.e. in
the subcutaneous tumor model that do not take into account the relationship σ(E))
showed that a very high electric field (E > Eirrev) was concentrated only in the stratum
corneum while the target tumor tissue was not treated (Figure 10A). Furthermore, the
volume of the target tumor tissue VT exposed to the E > Erev in the subcutaneous model
with constant conductivities of all tissue was zero (Figure 9A).
Conclusions
In our study we investigated whether the increase in electric conductivity of tissues
needs to be taken into account when modeling tissue response to the electroporation
pulses and how it affects the local electric distribution within electroporated tissues.
We examined electric field distribution during electroporation in both linear models
(i.e. tissue conductivity is constant) and non-linear models (i.e. tissue conductivity is
electric field dependent). The results show that nonlinear models fit experimental
data better than linear models. We demonstrated that the tissue conductivity as a
function of electric field (i.e. σ(E)) needs to be considered when modeling tissue be-
havior during electroporation. Therefore, the σ(E) relationship needs to be taken into
account when an electroporation based treatment is planned or investigated. The
findings of our study can be of great importance for precise treatment planning of
electroporation based therapies and treatments (e.g. for electrochemotherapy, gene
electrotransfer for gene therapy and DNA vaccination, tissue ablation with irrevers-
ible electroporation and transdermal drug delivery). Particularly, for an electropor-
ation based therapy of deep-seated cutaneous tumors and tumors in internal organs,
such as for example bone, brain or muscle tissue that are surrounded by other tis-
sues having different electric properties an individualized patient-specific treatment
planning that takes into account heterogeneity of electric conductivity and local elec-
tric field distribution within all exposed tissues is required.
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